Insider · CIK 0001448434

Keane Raymond T

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001448434

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-11	CGEMCullinan Therapeutics, Inc.A Award	Chief Legal Officer	AAward	+22.5K sh	—	—	24,124
2022-02-11	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+45K sh	—	—	45,000
2021-01-07	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Officer	AAward	+250K sh	—	—	249,998
2013-07-18	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−8,000 sh	$19.79	−$158K	62,096
2013-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+16K sh	—	—	70,096
2013-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	SVP General Counsel & CCO	AAward	+32K sh	—	—	32,000
2013-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−16K sh	—	—	16,000
2013-04-02	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−2,583 sh	$18.05	−$46.6K	54,096
2013-04-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+5,166 sh	—	—	56,679
2013-04-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−5,166 sh	—	—	0
2013-03-25	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−13.2K sh	$18.87	−$248K	51,513
2013-03-22	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+26.3K sh	—	—	64,680
2013-03-22	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−26.3K sh	—	—	0
2013-03-22	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−2,334 sh	$19.46	−$45.4K	38,347
2013-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+4,667 sh	—	—	40,681
2013-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−4,667 sh	—	—	0
2013-03-19	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	SVP General Counsel & CCO	AAward	+28.5K sh	—	—	28,500
2013-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP General Counsel & CCO	AAward	+14.3K sh	—	—	14,250
2012-12-18	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+7,750 sh	—	—	39,250
2012-12-18	ARIAD PHARMACEUTICALS INCF Tax Payment	SVP General Counsel & CCO	FTax Payment	−3,236 sh	$20.18	−$65.3K	36,014
2012-09-06	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+10K sh	$2.39	+$23.9K	41,500
2012-09-06	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−10K sh	$22.00	−$220K	31,500
2012-09-06	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−10K sh	—	—	50,000
2012-09-04	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−7,780 sh	$21.00	−$163K	31,500
2012-08-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+10K sh	$2.39	+$23.9K	49,280
2012-08-15	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−10K sh	$20.00	−$200K	39,280
2012-08-15	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−10K sh	—	—	60,000
2012-07-30	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−10K sh	$19.00	−$190K	39,280
2012-07-26	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+10K sh	$2.39	+$23.9K	59,280
2012-07-26	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−10K sh	$18.00	−$180K	49,280
2012-07-26	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−10K sh	—	—	70,000
2012-04-03	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−2,067 sh	$16.19	−$33.5K	48,980
2012-04-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+5,167 sh	—	—	51,047
2012-04-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−5,167 sh	—	—	10,333
2012-03-23	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−10.5K sh	$15.41	−$162K	45,880
2012-03-22	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+26.3K sh	—	—	56,713
2012-03-22	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−26.3K sh	—	—	26,333
2012-03-20	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−8,400 sh	$15.02	−$126K	30,380
2012-03-20	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	SVP General Counsel & CCO	AAward	+29K sh	—	—	29,000
2012-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP General Counsel & CCO	AAward	+14K sh	—	—	14,000
2012-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−21K sh	—	—	38,780
2012-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+21K sh	—	—	0
2012-02-14	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+12.5K sh	$1.30	+$16.3K	30,280
2012-02-14	ARIAD PHARMACEUTICALS INCS Sale	SVP General Counsel & CCO	SSale	−12.5K sh	$15.13	−$189K	17,780
2012-02-14	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−12.5K sh	—	—	12,500
2011-04-01	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	SVP General Counsel & CCO	AAward	+27K sh	—	—	27,000
2011-04-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP General Counsel & CCO	AAward	+15.5K sh	—	—	15,500
2011-03-22	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	+26.3K sh	—	—	26,334
2011-03-22	ARIAD PHARMACEUTICALS INCF Tax Payment	SVP General Counsel & CCO	FTax Payment	−8,554 sh	$6.39	−$54.7K	17,780
2011-03-22	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP General Counsel & CCO	MExercise/Conversion	−26.3K sh	—	—	52,666

Recent filings

Accepted (ET)
Feb 154
Keane Raymond T0000899243-22-006421
SEC(opens sec.gov)
Jan 114
Keane Raymond T0000899243-21-001359
SEC(opens sec.gov)
Jul 184
ARIAD PHARMACEUTICALS INC0001127602-13-023097
SEC(opens sec.gov)
Jul 174
ARIAD PHARMACEUTICALS INC0001127602-13-023055
SEC(opens sec.gov)
Apr 34
Keane Raymond T0001127602-13-013315
SEC(opens sec.gov)
Mar 264
Keane Raymond T0001127602-13-012016
SEC(opens sec.gov)
Mar 224
Keane Raymond T0001127602-13-011841
SEC(opens sec.gov)
Mar 204
Keane Raymond T0001127602-13-011540
SEC(opens sec.gov)
Dec 204
Keane Raymond T0001127602-12-034765
SEC(opens sec.gov)

Companies

Address

C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139